Post-approval studies (Phase 4)UnknownNCT00216229What this trial is testingTwinrix Alternative Schedule StudyWho this might be right forAntibody Response After Vaccination IDEWE Occupational Health Services 400
Large-scale testing (Phase 3)Study completedNCT05431933What this trial is testingStudy to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule With Bivalent OPV in InfantsWho this might be right forPoliomyelitisVaccine Reaction LG Chem 2,001
Post-approval studies (Phase 4)Study completedNCT03294135What this trial is testingThe Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults VaccineWho this might be right forVirus Diseases GlaxoSmithKline 194
Post-approval studies (Phase 4)Study completedNCT00310713What this trial is testingPersistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC VaccineWho this might be right forPrevention of Meningococcal Infection Novartis Vaccines 33
Early research (Phase 1)Study completedNCT00279734What this trial is testingVaccination Study of Abatacept (BMS-188667) for Normal Healthy VolunteersWho this might be right forRheumatoid Arthritis Bristol-Myers Squibb 80
Not applicableStudy completedNCT05057936What this trial is testingAntibody After COVID-19 VaccinationWho this might be right forCovid19Breakthrough InfectionCKD+2 more Bangkok Metropolitan Administration Medical College and Vajira Hospital 140
Testing effectiveness (Phase 2)Study completedNCT02451514What this trial is testingEvaluate 4-year Antibody Persistence and Booster Response Following MenABCWY Vaccination in Healthy Adolescents and Young Adults Who Previously Participated in Studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158)Who this might be right forMeningococcal DiseaseInfections, Meningococcal GlaxoSmithKline 129
Large-scale testing (Phase 3)Study completedNCT01139021What this trial is testingOne Year Antibody Persistence After a Fourth Dose Boost or Two Catch-Up Doses of Novartis Meningococcal B Recombinant Vaccine Administered Starting From 12 Months of Age and Response to a Third Dose Boost or Two Catch-Up Doses Starting at 24 Months of AgeWho this might be right forMeningococcal Disease Novartis Vaccines 508
Post-approval studies (Phase 4)Study completedNCT02446691What this trial is testingEvaluation of Antibody Persistence Following 4 MenACWY VaccinationsWho this might be right forInfections, Meningococcal GlaxoSmithKline 128
Testing effectiveness (Phase 2)Study completedNCT02946385What this trial is testingStudy to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in AdolescentsWho this might be right forInfections, Meningococcal GlaxoSmithKline 604
Not applicableUnknownNCT05145348What this trial is testingProspective Monitoring of Antibody Response Following COVID-19 Vaccination in Patients With Down Syndrome.Who this might be right forDown SyndromeSARS-CoV-2 Vaccination UMC Utrecht 640
Not applicableStudy completedNCT05490342What this trial is testingEffect of SARS-CoV-2 Vaccination in Liver Transplant RecipientsWho this might be right forSARS-CoV-2 VaccinationLiver Transplantation University of Rome Tor Vergata 61
Post-approval studies (Phase 4)Study completedNCT00503529What this trial is testingTBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)Who this might be right forEncephalitis, Tick-Borne Pfizer 314
Not applicableStudy completedNCT00962819What this trial is testingMeasles, Mumps, and Rubella (MMR) Immunity in College StudentsWho this might be right forMeaslesMumpsRubella Sri Edupuganti, MD MPH 74
Testing effectiveness (Phase 2)Study completedNCT03719066What this trial is testingExtended Dose Intervals With Oral Cholera Vaccine in CameroonWho this might be right forAdverse Reaction to Cholera VaccineCholera Vaccination Reaction Johns Hopkins Bloomberg School of Public Health 181
Testing effectiveness (Phase 2)Study completedNCT01239043What this trial is testingAntibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial VaccinationWho this might be right forMeningitisMeningococcal MeningitisMeningococcal Infections Sanofi 139
Post-approval studies (Phase 4)Study completedNCT00316654What this trial is testingPersistence of Antibody Response to N. Meningitidis Group C in ChildrenWho this might be right forPrevention of Meningococcal Infection Novartis Vaccines 489
Not applicableEnded earlyNCT05142540What this trial is testingDetection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster VaccinesWho this might be right forAnti-SARS-CoV-2 Antibody Response Medical University of Graz 140
Not applicableStudy completedNCT00889278What this trial is testingHigher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell TransplantationWho this might be right forLymphoma Dartmouth-Hitchcock Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT05077254What this trial is testingCOVID Protection After Transplant-Immunosuppression ReductionWho this might be right forKidney Transplant RecipientsLiver Transplant Recipients National Institute of Allergy and Infectious Diseases (NIAID) 48